Telix Pharmaceuticals Limited (TLX)

Telix Pharmaceuticals Limited (TLX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.8B; returns 1 day -4.1%, 1 week -14.4%, 1 year -15.9%.

Telix Pharmaceuticals Limited (NASDAQ: TLX) is a biopharmaceutical company headquartered in Melbourne, Australia, focused on developing and commercializing therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Their strategy revolves around expanding Illuccix distribution and investing in their product pipeline.

Groups TLX belongs to

• Biotechnology
• Biopharmaceutical
• Oncology
• Cancer Therapeutics
• Health Diagnostics and Imaging
• Healthcare
• Commercial Stage Biotech
• Life Sciences
• Precision Medicine
• Healthcare Technology
• Medical Devices

TLX financial model: income statement, cash flow and balance sheet